News & Events - Press Release In 2023

Read News By Date

The Use of HemogloBind™ in Proteomic Analysis of Programmed Death of Red Blood Cells

MONMOUTH JUNCTION, NJ, December 13, 2023 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of HemogloBind™, to remove Hemoglobin interference prior to LC-MS proteomic analysis of red blood cells.
Read More

Research Articles Cites HemogloBind™ to Remove Analytical Interference from Abdominal Aorta Lysates

Cleanascite™ Employed to Determine Role of Lipid-Associated Factors in Myofibroblast Conversion

MONMOUTH JUNCTION, NJ, December 12, 2023 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation technology to determine the role of lipid-associated factors in adipocyte signaling and fibroblast to myofibroblast conversion .
Read More

Journal Article Cites Cleanascite™ for Purification of Monoclonal Antibody used in Prostate Cancer Research

MONMOUTH JUNCTION, NJ, November 14, 2023 -- Biotech Support Group reports on a journal research article describing the simplicity and efficiency of their lipid clarification technology for purifying a monoclonal antibody from ascites fluid.
Read More

Two Research Articles Cite HemogloBind™ to Remove Analytical Interference from Hemoglobin

MONMOUTH JUNCTION, NJ, October 17, 2023 -- Biotech Support Group reports on two journal articles describing the simplicity and efficiency of HemogloBind™, to remove Hemoglobin interferences prior to analysis.
Read More

Research Article Cites Cleanascite™ for Purification of Lysyl oxidase (LOX)

MONMOUTH JUNCTION, NJ, October 17, 2023 -- Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their lipid binding technology for purifying and analyzing Lysyl oxidase (LOX) from bovine aorta.
Read More

Journal Article Cites HemoVoid™ in Nanopore Analysis of α-Synuclein Post-translational Modifications

MONMOUTH JUNCTION, NJ, October 16, 2023 -- Biotech Support Group reports on a research article describing the simplicity and efficiency of their HemoVoid™ technology for enriching erythrocyte low abundance proteins, in order to assess post-translational modifications of α-synuclein through a biological nanopore.
Read More

HemogloBind™ Used in Study of Sickle Cell Disease

MONMOUTH JUNCTION, NJ, September 14, 2023 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of HemogloBind™, to remove Hemoglobin interference, in a study investigating sickle cell disease.
Read More

Journal Article Cites AlbuSorb™ in Study of Intestinal Microbiota and Systemic Immunity

MONMOUTH JUNCTION, NJ, August 21, 2023 -- Biotech Support Group reports on a recent journal article using AlbuSorb™ to determine the how Albumin buffers the inflammatory impact of glycoconjugates derived from intestinal Firmicute cell walls.
Read More

Nature Article Cites NuGel™-HemogloBind™ in Study of Reprogramming Tumour-associated Macrophages

MONMOUTH JUNCTION, NJ, July 17, 2023 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of NuGel™ HemogloBind™, to remove Hemoglobin interference, in a LC-MS amino acid analysis of mouse tumor interstitial fluid.
Read More

Research Article Cites Cleanascite™ for Purification of Coupled Perfluorocarbon Nanoparticles

MONMOUTH JUNCTION, NJ, July 17, 2023 -- Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their lipid binding technology for purifying coupled nanoparticles.
Read More

Cleanascite™ Employed to Help Determine Role of Fatty Acids in Multiple Myeloma

MONMOUTH JUNCTION, NJ, June 14, 2023 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance sample preparation technology to help determine the role of fatty acids in the suppression of T cell function in the bone marrow microenvironment.
Read More

Cleanascite™ Employed To Investigate Lipid Pathway Influences on Hepatocellular Carcinoma

MONMOUTH JUNCTION, NJ, May 11, 2023 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid binding technology to determine the influence of lipid LTB4R2 ligands within pathways associated with Hepatocellular carcinoma.
Read More

Biotech Support Group to exhibit at the 71st ASMS Conference on Mass Spectrometry and Allied Topics, June 4 - 8, 2023 in Houston, Texas

MONMOUTH JUNCTION, NJ, May 4, 2023 -- Biotech Support Group will exhibit at the annual American Society for Mass Spectrometry (ASMS) Conference, June 4-8, 2023 in Houston, TX.The conference highlights the most recent advancements in Mass Spectrometry technology and applications, with attendance of 6,000 – 7,000 scientists and over 2,700 poster presentations and 384 talks.
Read More

HemogloBind™ Used in Study of Erythrocytotoxicity

MONMOUTH JUNCTION, NJ, March 24, 2023 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of HemogloBind™, to remove Hemoglobin interference, in a study investigating erythrocytotoxicity from silica nanoparticles (SiNPs).
Read More

Research Article Cites Cleanascite™ for Proteomic Screening of Novel Biomarkers in Bile

MONMOUTH JUNCTION, NJ, March 22, 2023 -- Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their lipid clearance sample preparation technology for proteomic screening of novel biomarkers in bile fluid.
Read More

Metabolomic Analysis Method Adopts NuGel™-HemogloBind™ in Study of Adults with Epilepsy

MONMOUTH JUNCTION, NJ, February 16, 2023 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of NuGel™ HemogloBind™, to remove Hemoglobin interference, in a LC-MS metabolomic analysis of plasma in a dietary study of adults with epilepsy.
Read More

HemogloBind™ Employed In A Nano LC−MALDI MS/MS Method for Identifying Single Mutation Hemoglobin Variants

MONMOUTH JUNCTION, NJ, February 9, 2023 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of HemogloBind™, to purify Hemoglobin, in a nano LC−MALDI MS/MS measurement of single amino acid mutations in Hb variants.
Read More

The role of fatty acids in Multiple Myeloma Microenvironments is investigated through the use of Cleanascite™

MONMOUTH JUNCTION, NJ, January 31, 2023 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid binding technology to determine the influence long-chain fatty acids on CD8+ T cell metabolism and function in Multiple Myeloma.
Read More

Cleanascite™ Employed to Investigate Membrane Vesicle Influences on Bacterial Biofilms

MONMOUTH JUNCTION, NJ, January 27, 2023 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid binding technology to determine the influence of probiotic membrane vesicles on antimicrobial activity.
Read More

Research Article Describes the Use of Cleanascite™ In the Purification of HDL-Bound small RNAs

MONMOUTH JUNCTION, NJ, January 12, 2023 -- Biotech Support Group reports on a research article describing the simplicity and efficiency of their lipid clearance sample preparation technology in a two step purification method for High-density lipoproteins (HDLs) in order to measure transport amounts of small RNAs.
Read More

A Mini-Review Describes the Analytical Aspects of Liquid chromatography – Mass spectrometry (LC-MS) Methods Aimed at Quantification of Stroma Liquid Biopsy™ Proteins in Body Fluids

MONMOUTH JUNCTION, NJ, January 9, 2023 -- Biotech Support Group (BSG) reports on joint publication with authors from research collaborators at Leiden University Medical Center, describing the developmental and analytical aspects of Tier 2 LC-MRM-MS protein quantification methods for liquid biopsies, with a special focus on BSG’s Stroma Liquid Biopsy™ protein panel.
Read More

Research article employed HemogloBind™ to remove analytical interferences due to Hemoglobin

MONMOUTH JUNCTION, NJ, January 9, 2023 -- Biotech Support Group reports on a journal article describing the simplicity and efficiency of HemogloBind™, Hemoglobin depletion technology for removing analytical interferences, in the measurement of Acetylcholinesterase and Butyryl cholinesterase activity.
Read More

Cleanascite™ Employed to Investigate Lipid Influence in Tumor-associated macrophages (TAMs)

MONMOUTH JUNCTION, NJ, January 9, 2023 -- Biotech Support Group reports on an article, describing the simplicity and efficiency of their lipid clearance technology for depletion of lipids from omental conditioned medium (OCM) to determine their influence on tumor-associated macrophages (TAMs)
Read More

News & Events - Press Release In 2023

Company

Support